EMAIL THIS PAGE TO A FRIEND

The Medical journal of Malaysia

Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.


PMID 23082426

Abstract

Penicillamine toxicity in Wilson's disease has been well reported but rarely seen now as newer agents are being used. We present a case who developed multiple rare complications of Penicillamine concurrently. Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later. All the adverse effects improved soon after substitution of the offending agent with Trientine.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P4875
D-Penicillamine, 98-101%
C5H11NO2S